
From 1x to 10x: What AI Agents Actually Automate
A data-driven breakdown of which software development tasks AI agents like FutureX can take over and which still demand a human developer.
Tag archive

A data-driven breakdown of which software development tasks AI agents like FutureX can take over and which still demand a human developer.

A technical comparison of FutureX, Microsoft Agent Framework, and AutoGen across multi-agent orchestration models, deployment maturity, and production readiness in 2026.
FutureX turns historical medical research into a prediction engine for drug discovery pipelines, helping public health AI prioritize the most promising medical breakthroughs.

A technical comparison of FIM's FutureX against Microsoft Agent Framework, covering ease of use, scalability, and control across team sizes.

Learn how to move from vibe coding to production with FutureX, a technical guide for solo developers scaling AI coding into enterprise-grade workflows.
Clinicians are bypassing vendor roadmaps and vibe coding their own medical software with FutureX — here's how it works and what it means for digital health.
A technical comparison of FutureX with Claude Artifacts, Cursor, and Replit for building clinical decision support bots that meet compliance and integration demands.

A concrete guide to pairing junior hires with the FutureX coding agent to ship agentic AI workflows in weeks, not months.

Compare FutureX Starter, Engineer, and Enterprise plans to find the right subscription tier for your agentic coding workflow, from solo developers to large teams.

FutureX embeds data leak prevention at every layer of the AI coding workflow, turning enterprise codebases into secure, policy-controlled assets.

The centralization-vs-decentralization AI debate shapes vibe coding directly through model access, costs, and innovation, and model-agnostic agents like FutureX keep your workflows open.
A hands-on walkthrough of vibe coding a clinical decision support bot with FutureX, turning ScienceDaily headlines about GLP-1 and gene therapy into structured alerts.